NMPA accepts clinical trial application for monkeypox vaccine
chinadaily.com.cn |
Updated: 2023-07-14 19:44
Share
Share - WeChat
The National Medical Products Administration (NMPA) has, on Thursday, officially accepted the clinical trial application for the replication-deficient monkeypox vaccine developed by China National Pharmaceutical Group Corporation (Sinopharm) Beijing Institute of Biological Products.
- Thousands of quake-hit Xizang residents move into new homes
- Stage truss collapse in Sichuan kills 2, injures 3
- Hotan hosts cultural heritage showcase
- Regional commodity fair opens in Xinjiang
- Jiangxi assistance helps Xinjiang community thrive
- 'Terracotta Warriors' show their dance moves at Beijing games
